About
Paradigm Therapeutics is a biopharmaceutical company developing innovative therapies for rare diseases, with a lead topical treatment, Zorblesia™, aimed at healing wounds and lesions across the entire skin surface for patients with all subtypes of Epidermolysis Bullosa (EB).
Explore Paradigm Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.